ALPRAZOLAM PLUS 1 ALP+ 1 V2 S SH

GUDID B800ALP1V2SSH5

ALPRAZOLAM PLUS 1

UTAK LABORATORIES, INC.

Multiple-type clinical chemistry analyte profile IVD, control
Primary Device IDB800ALP1V2SSH5
NIH Device Record Keycaba2381-2722-413f-9541-f80f73e928c5
Commercial Distribution StatusIn Commercial Distribution
Brand NameALPRAZOLAM PLUS 1
Version Model NumberALP+ 1 V2 S SH
Catalog NumberALP+ 1 V2 S SH
Company DUNS092519016
Company NameUTAK LABORATORIES, INC.
Device Count1
DM Exemptfalse
Pre-market Exempttrue
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kitfalse
Device Combination Productfalse
Single Usefalse
Lot Batchtrue
Serial Numberfalse
Manufacturing Datefalse
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptionfalse
OTC Over-The-Counterfalse

Customer Support Contacts

Phone1-888-882-5522
Emailwelovecontrol@utak.com
Phone1-888-882-5522
Emailwelovecontrol@utak.com
Phone1-888-882-5522
Emailwelovecontrol@utak.com

Device Dimensions

Total Volume3 Milliliter
Total Volume3 Milliliter
Total Volume3 Milliliter

Operating and Storage Conditions

Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius

Device Identifiers

Device Issuing AgencyDevice ID
HIBCCB800ALP1V2SSH0 [Primary]
HIBCCB800ALP1V2SSH5 [Package]
Contains: B800ALP1V2SSH0
Package: BOX [17 Units]
In Commercial Distribution

FDA Product Code

LASDrug Specific Control Materials

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusNew
Device Record StatusPublished
Public Version Number1
Public Version Date2025-01-23
Device Publish Date2025-01-15

Devices Manufactured by UTAK LABORATORIES, INC.

B800ALP1V2SSH5 - ALPRAZOLAM PLUS 1 2025-01-23ALPRAZOLAM PLUS 1
B800ALP1V2SSH5 - ALPRAZOLAM PLUS 1 2025-01-23 ALPRAZOLAM PLUS 1
B800ALP2V2SSH0 - ALPRAZOLAM PLUS 22025-01-23 ALPRAZOLAM PLUS 2
B800IMIP1000SFUW5 - IMIPRAMINE 1000 NG/ML2025-01-22 IMIPRAMINE 1000 NG/ML
B80091801UAL5 - BUPRENORPHINE HYDROLYSIS QC2025-01-21 BUPRENORPHINE HYDROLYSIS QC
B800MDLABS43V2HIGH0 - MD LABS 43 DRUGS HIGH2025-01-21 MD LABS 43 DRUGS HIGH
B800MDLABS43V2LOW5 - MD LABS 43 DRUGS LOW2025-01-21 MD LABS 43 DRUGS LOW
B800DOA1EXTBUFOFFMMC5 - DRUGS OF ABUSE LEVEL 1 2025-01-20 DRUGS OF ABUSE LEVEL 1
B800DOA2EXTBUFOFFMMC5 - DRUGS OF ABUSE LEVEL 2 2025-01-20 DRUGS OF ABUSE LEVEL 2

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.